Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis
Open Access
- 14 February 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Gastroenterology
- Vol. 12 (1), 14
- https://doi.org/10.1186/1471-230X-12-14
Abstract
Background The aspartate aminotransferase-to-platelet ratio index (APRI), a tool with limited expense and widespread availability, is a promising noninvasive alternative to liver biopsy for detecting hepatic fibrosis. The objective of this study was to systematically review the performance of the APRI in predicting significant fibrosis and cirrhosis in hepatitis B-related fibrosis. Methods Areas under summary receiver operating characteristic curves (AUROC), sensitivity and specificity were used to examine the accuracy of the APRI for the diagnosis of hepatitis B-related significant fibrosis and cirrhosis. Heterogeneity was explored using meta-regression. Results Nine studies were included in this meta-analysis (n = 1,798). Prevalence of significant fibrosis and cirrhosis were 53.1% and 13.5%, respectively. The summary AUCs of the APRI for significant fibrosis and cirrhosis were 0.79 and 0.75, respectively. For significant fibrosis, an APRI threshold of 0.5 was 84% sensitive and 41% specific. At the cutoff of 1.5, the summary sensitivity and specificity were 49% and 84%, respectively. For cirrhosis, an APRI threshold of 1.0-1.5 was 54% sensitive and 78% specific. At the cutoff of 2.0, the summary sensitivity and specificity were 28% and 87%, respectively. Meta-regression analysis indicated that the APRI accuracy for both significant fibrosis and cirrhosis was affected by histological classification systems, but not influenced by the interval between Biopsy & APRI or blind biopsy. Conclusion Our meta-analysis suggests that APRI show limited value in identifying hepatitis B-related significant fibrosis and cirrhosis.Keywords
This publication has 37 references indexed in Scilit:
- Staging of liver fibrosis in chronic hepatitis B patients with a composite predictive model: A comparative studyWorld Journal of Gastroenterology, 2010
- Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseasesThe Esophagus, 2008
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- Sampling variability of liver fibrosis in chronic hepatitis CHepatology, 2003
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology, 2003
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996
- Is day case liver biopsy underutilised?Gut, 1995
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991
- Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsiesJournal of Hepatology, 1986